Program Schedule Session 1: Friday 2:30 – 3:50pm Time of Room: Broadway 1 Room: Broadway 2 Room: Broadway 3 Room: Broadway 4 Room: Phila Room: Travers Presentations Infectious Disease Infectious Disease Nephrology / Cardiology Pediatrics Am Care Anticoagulation Moderator Dr. Caitlyn Cummings Dr. Thomas Lombardi Dr. Daniella Rodrigues Ferri Dr. Julie Bennett Dr. Lisa Phillips Dr. John Papadopoulos Evaluators Dr. Brian Kersten Dr. Bejoy Maniara Dr. Samantha Liaw Dr. Carley Luker Dr. Stephanie Ross Dr. Robert DiGregorio Dr. Lisa Voigt Dr. Amy Wojciechowski Dr. Danielle Casile Dr. Jeffrey Kennicutt Dr. Nandini Sabharwal Dr. Mark Sinnett 2:30pm – EVALUATING THE IDENTIFICATION OF EVALUATION OF TOLVAPTAN EVALUATION OF ENOXAPARIN PHARMACIST IMPACT ON EVALUATION AND CLINICAL 2:50pm APPROPRIATENESS OF HEALTHCARE-ASSOCIATED IN HOSPITALIZED PATIENTS DOSING AND MONITORING IN DIABETES CARE IN A FAMLY OUTCOMES OF PERI- INTRAVENOUS BETA-LACTAM PNEUMONIA RISK FACTORS Juby Panicker, PharmD PEDIATRIC PATIENTS AT A MEDICINE CLINIC PROCEDURAL INTERRUPTION ANTIBIOTICS CLEARED BY AMONG PATIENTS WITH Albany Medical Center TERTIARY CARE CENTER Jenna McGreevy, PharmD OF DIRECT ORAL INTERMITTENT COMMUNITY-ACQUIRED Salma Aziz, PharmD St. Joseph’s Health Center, ANTICOAGULANTS AND HEMODIALYSIS PNEUMONIA The Mount Sinai Hospital Wegmans School of Pharmacy WARFARIN IN PATIENTS Kevin Won, PharmD Nirvana Awad, PharmD UNDERGOING Long Island Jewish Medical Montefiore Nyack Hospital INTERVENTIONAL RADIOLOGY Center PROCEDURES Kassandra Marsh, PharmD NYU Langone Health 2:50pm - EVALUATING THE RISK OF COMPARISON OF ANTIBIOTIC OPTIMAL DIURETIC DOSING EVALUATION OF ENOXAPARIN EVALUATION OF DIABETES EVALUATION OF THE 3:10pm NEPHROTOXICITY WITH HIGH PRESCRIBING PATTERNS FOR STRATEGY IN ACUTE DOSING IN A PEDIATRIC PATIENT CARE INDICATORS IN EFFECTIVENESS OF DOSE VANCOMYCIN COMMUNITY-ACQUIRED DECOMPENSATED HEART CRITICAL CARE UNIT A PRIMARY CARE CLINIC IDARUCIZUMAB IN THE Dennis Huang, PharmD PNEUMONIA IN A TERTIARY FAILURE PATIENTS Wen-Ling Kyon, PharmD Luke Sanna, PharmD SUSTAINED REVERSAL OF North Shore University MEDICAL CENTER Majid Shafi, PharmD Montefiore Medical Center St. John Fisher College ANTICOAGULATION IN Hospital Mario Beccari, PharmD Mount Sinai St. Luke’s Hospital PATIENTS WITH RENAL Buffalo General Medical Center DYSFUNCTION Jessica Morales, PharmD Southside Hospital 3:10pm – DEFINING AREA UNDER THE IMPACT OF TRANSITIONS OF PHARMACIST DRIVEN EMPIRIC TREATMENT OF IMPACT OF A PHARMACIST IN EVALUATION OF PRESCRIBING 3:30pm CONCENTRATION-TIME CURVE CARE ANTIMICROBIAL MEDICATION CULTURE POSITIVE SKIN AND A CARDIOMETABOLIC PATTERNS AND DEVIATIONS THRESHOLDS FOR PHARMACY SERVICES IN AN RECONCILIATION PROGRAM SOFT TISSUE INFECTIONS OF MONITORING PROGRAM IN IN APIXABAN DOSING VANCOMYCIN EFFICACY AND URBAN MEDICAL CENTER DIRECTED AT PATIENTS WITH THE PEDIATRIC POPULATION AN OUTPATIENT PSYCHIATRIC SECONDARY TO RENAL NEPHROTOXICITY: A Erika Da Costa, PharmD A PRIMARY DIAGNOSIS OF IN A DOWNTOWN BROOKLYN CLINIC DYSFUNCTION IN AN URBAN PRACTICAL APPROACH USING The Brookdale Hospital ACUTE HEART FAILURE HOSPITAL Nicole Banks, PharmD ACADEMIC MEDICAL CENTER TWO-POINT Medical Center EXACERBATION Margaret Marshall, PharmD BronxCare Health System, Katarina Stelzer, PharmD PHARMACOKINETICS IN Andrew Karas, PharmD The Brooklyn Hospital Center Montefiore Medical Center METHICILLIN-RESISTANT Mount Sinai Beth Israel STAPHYLOCOCCUS AUREUS BACTEREMIA Bryan Mogle, PharmD SUNY Upstate University Hospital 3:30pm – ASSESSING THE CHANGE IN IMPLEMENTATION OF AN IDENTIFYING THE GAPS IN THE EVALUATION OF THE SAFETY IMPACT OF A CERTIFIED EFFECTS OF 3:50pm RENAL FUNCTION FOR EXTENDED-INFUSION GUIDELINES: HOW MANY AND EFFECTIVENESS OF A ASTHMA EDUCATOR HYPOALBUMINEMIA ON RISK HEPATITIS B PATIENTS WHEN PIPERACILLIN-TAZOBACTAM PATIENTS ON APPROPRIATE NEW VITAMIN D PHARMACIST ON THE OF BLEEDING IN PATIENTS SWITCHING FROM TENOFOVIR PROTOCOL IN THE MEDICAL INTENSITY STATIN THERAPY SUPPLEMENTATION PERSISTENT ASTHMA TREATED WITH RIVAROXABAN DISOPROXIL FUMARATE TO INTENSIVE CARE UNIT MAY QUALIFY FOR PROTOCOL IN A CYSTIC MEDICATION MANAGEMENT Liz Wojakowski, PharmD TENOFOVIR ALAFENAMIDE Byron Alston, PharmD ADDITIONAL LIPID LOWERING FIBROSIS POPULATION MEASURE IN AN INNER-CITY Buffalo General Medical Center Minna Lee, PharmD The Mount Sinai Hospital THERAPY? Alexandra Kibler, PharmD PULMONARY CLINIC North Shore University Tatyana Bazarova, PharmD SUNY Upstate University Caitlyn Bloom, PharmD Hospital The Brooklyn Hospital Center, BronxCare Health System Long Island University
Session 2: Friday 4:00 – 5:00pm Time of Room: Broadway 1 Room: Broadway 2 Room: Broadway 3 Room: Broadway 4 Room: Phila Room: Travers Presentations Infectious Disease Infectious Disease Critical Care Stroke Am Care Diabetes Moderator Dr. Magdalena Wrzesinski Dr. Lukas Waller Dr. Deep Patel Dr. Robert Seabury Dr. Caitlyn Bloom Dr. Anne Niemiec Evaluators Dr. Michelle Lewis Dr. Jeffrey Kennicutt Dr. Brian Kersten Dr. Mark Sinnett Dr. Susan Fill Dr. Rubiya Kabir Dr. Amy Wojciechowski Dr. See-Won Seo Dr. Lisa Voigt Dr. John Fill Dr. Timothy Vink Dr. Alecia Wyckoff 4:00pm – IMPACT OF EFFECT OF ORAL CLONIDINE USE AND THE EVALUATION OF A EVALUATING THE MANAGEMENT OF ACUTE 4:20pm ANTIMICROBIAL VANCOMYCIN DOSING INCIDENCE OF STROKE STRETCHER AND IMPACT OF HYPERKALEMIA USING A STEWARDSHIP ON ON CLINICAL OUTCOMES WITHDRAWAL IN ITS EFFECTS ON AMBULATORY CARE STANDARDIZED, FLUOROQUINOLONE OF CLOSTRIDIUM PEDIATRIC PATIENTS ALTEPLASE DOSING AND CLINICAL PHARMACISTS EVIDENCE-BASED ORDER UTILIZATION IN THE DIFFICILE INFECTION WHO RECEIVED ASSOCIATED OUTCOMES ON MEDICATION SET AND ITS ROLE IN OUTPATIENT SETTING AT Gurkirat Singh, PharmD PROLONGED Rebecca Marcinak, UNDERSTANDING AND REDUCING AN ACADEMIC MEDICAL Albany Medical Center DEXMEDETOMINE PharmD ADHERENCE HYPOGLYCEMIC EVENTS CENTER INFUSIONS Upstate University Theo Pham, PharmD Stephanie Lim, PharmD Yousef Lafi, PharmD Erin Beitz, PharmD Hospital Mount Sinai West St. Francis Hospital, The BronxCare Health System Upstate Golisano Hospital, Heart Center Children’s Hospital Mount Sinai St. Luke’s Hospital 4:20pm – IMPLEMENTATION OF A EFFICACY OF ORAL DECREASED USE OF LOW-DOSE HEPARIN EFFICACY OF THE SINGLE EVALUATION OF EMPIRIC 4:40pm TRANSITION OF CARE VANCOMYCIN FOR PROTON PUMP INFUSIONS FOR ACUTE ITEM LITERACY SCREENER INSULIN GLARGINE DOSE PROTOCOL IN PATIENTS SECONDARY INHIBITORS FOR STRESS ISCHEMIC STROKE QUESTIONNAIRE IN REDUCTION ON WITH INFECTIOUS PROPHYLAXIS OF ULCER PROPHYLAXIS Rachael Scott, PharmD OPTIMIZING THE ROLE OF INPATIENT DISEASES AT A RECURRENT Jessica Maas, PharmD Buffalo General Medical A CLINICAL PHARMACIST HYPOGLYCEMIC EVENT COMMUNITY HOSPITAL CLOSTRIDIUM DIFFICILE Long Island Jewish Center IN THE AMBULATORY RATES Phi Oanh Dang, PharmD INFECTION Medical Center CARE SETTING Allison Zuern, PharmD Mount Sinai Brooklyn Kendra Nielsen, PharmD Joseph Graber, PharmD SUNY Upstate University Kingsbrook Jewish Mercy Hospital of Buffalo Hospital Medical Center 4:40pm – IDENTIFICATION OF RISK OUTCOMES ASSOCIATED 3% HYPERTONIC SALINE RISKS OF INTRACRANIAL EVALUATION OF PATIENT IMPACT OF AUTOMATIC 5:00pm FACTORS FOR WITH ORAL VERSUS HYPERTONIC HEMORRHAGE: A PRIORITIZATION THERAPEUTIC PSEUDOMONAS VANCOMYCIN DOSING IN SALINE WITH SODIUM RETROSPECTIVE SCORING METHODS IN SUBSTITUTION ON AERUGINOSA IN PATIENTS WITH ACETATE FOR ANALYSIS OF ALTEPLASE AN ADULT MEDICINE MEDICATION PATIENTS WITH FOOT CLOSTRIDIUM DIFFICILE INTRACRANIAL PRESSURE USE FOR TREATMENT OF RESIDENCY CLINIC PRESCRIBING AT INFECTIONS RELATED TO INFECTION REDUCTION: A ACUTE ISCHEMIC STROKE Anne Krasniak, PharmD HOSPITAL DISCHARGE: A DIABETES AND/OR Gregory Novak, PharmD RETROSPECTIVE IN PATIENTS 80 YEARS Upstate University FOCUS ON LONG-ACTING PERIPHERAL VASCULAR St. Peter's Hospital ASSESSMENT OF SAFETY AND OLDER Hospital INSULIN DISEASES AND EFFICACY Sarah Krizan, PharmD Alison Milbrand, PharmD Feng Lin, PharmD Francine Yung, PharmD Long Island Jewish St. Joseph's Health, Mount Sinai West Albany Medical Center Medical Center Wegmans School of Hospital, Pharmacy, St. John Fisher Mount Sinai St. Luke’s College Hospital
Session 3 : Saturday 9:00 – 10:20am Time of Room: Broadway 1 Room: Broadway 2 Room: Broadway 3 Room: Broadway 4 Room: Phila Room: Travers Presentations Infectious Disease Practice Management/ Critical Care Emergency Medicine Anticoagulation / Geriatrics Transplant Medicine / Pain Management Moderator Dr. Matt Zak Dr. Benjamin Wee Dr. Marshall Grignon Dr. Kristen Bulmer Dr. Agnieszka Pasternak Dr. Liz Wojakowski Evaluators Dr. Elizabeth Shlom Dr. Michelle Lewis Dr. Devin Holden Dr. Danielle Casile Dr. Lindsey Feuz Dr. Ellen Giordano Ms. Karen Whalen Dr. Timothy Vink Dr. Lukas Waller Dr. Rochelle Rubin Dr. Emma Gorman Dr. Jaclyn Scott 9:00am – CHARACTERIZING ASSESSING PRESCRIBING EVALUATION OF DIGOXIN EVALUATION OF AN APPLYING DELTA-INR TO IMPACT OF DELAYING 9:20am PRESCRIBING PRACTICES TRENDS AND FINANCIAL CONCENTRATION AFTER EMERGENCY DEPARTMENT WARFARIN DOSING FLUOROQUINOLONE OF DAPTOMYCIN AND IMPACT POST UPGRADE OF LOADING DOSE IN PHARMACY DISCHARGE Nicholas Fausto, PharmD PROPHYLAXIS IN CEFTAROLINE FOSAMIL IN COMPUTERIZED PHYSICIAN CRITICALLY ILL PATIENTS ASSISTANCE PILOT Huntington Hospital ALLOGENEIC A TERTIARY CARE ORDER ENTRY SYSTEM IN A Raghad Saadi, PharmD PROGRAM IN AN URBAN HEMATOPOIETIC STEM HOSPITAL TERTIARY HOSPITAL NYU Langone Health MEDICAL CENTER CELL TRANSPLANTATION Marlee Mangino, PharmD WITHIN A LARGE Robert O’Connell, PharmD FROM DAY 0 TO St. Peter’s Hospital HEALTHCARE NETWORK Brookdale University NEUTROPENIA ON PATIENT Karina Soares, PharmD Hospital Medical Center OUTCOMES Lenox Hill Hospital Sweta Patel, PharmD The Mount Sinai Hospital 9:20am – CHOICE OF ORAL EVALUATION OF PROTOCOLIZED APPROACH IMPACT OF ROUND-THE- A RETROSPECTIVE POSACONAZOLE VERSUS 9:40am STEPDOWN THERAPY ADMINISTRATION TO THE MANAGEMENT OF CLOCK EVALUATION OF VORICONAZOLE AS EFFECT ON READMISSION DISCREPANCIES BETWEEN ALCOHOL WITHDRAWAL PHARMACOTHERAPY PHARMACIST-DRIVEN ANTIFUNGAL RATES IN ESCHERICHIA CHEMOTHERAPY AND Joseph Palumbo, PharmD CONSULTATION SERVICE IN ENOXAPARIN DOSING FOR PROPHYLAXIS DURING COLI BACTEREMIA SUPPORTIVE CARE PLANS Buffalo General Medical THE EMERGENCY VTE PROPHYLAXIS IN INDUCTION THERAPY FOR Julia Sessa, PharmD IN A NEWLY ESTABLISHED Center DEPARTMENT CRITICALLY ILL TRAUMA ACUTE MYELOGENOUS St. Joseph’s Health, COMPUTERIZED PHYSICIAN Kwong Lau, PharmD PATIENTS LEUKEMIA OR St. John Fisher Wegmans ORDER ENTRY (CPOE) The Brooklyn Hospital Ali Scrimenti, PharmD MYELODYSPLASTIC School of Pharmacy Emily Messing, PharmD Center Upstate University Hospital SYNDROME Montefiore Medical Center Kynlon Phillips, PharmD NYU Langone Health 9:40am – ASSESSING EVALUATING THE IMPACT EVALUATION OF EFFICACY OF IV EVALUATION OF A LONG- IMPACT OF RECIPIENT AND 10:00am ANTIMICROBIAL OF TECHNOLOGY SUGAMMADEX FOR ACETAMINOPHEN ACTING OPIOID DONOR CYP3A5 and ABCB1 PRESCRIBING PATTERNS UTILIZATION BY NEUROMUSCULAR COMPARED TO IV RESTRICTION POLICY AND GENOTYPE ON WEIGHT- FOR ASYMPTOMATIC PROVIDERS ON REDUCING BLOCKADE REVERSAL IN KETOROLAC ON PAIN ITS EFFECTS ON OPIOID ADJUSTED TACROLIMUS BACTERIURIA IN THE MEDICATION ERRORS ON THE OPERATING ROOMS SCORES WHEN USED FOR PRESCRIBING TROUGH/DOSE EMERGENCY DEPARTMENT ADMISSION OF A LARGE URBAN THE MANAGEMENT OF Jenna Fancher, PharmD CONCENTRATIONS IN SETTING Jessica Tran, PharmD ACADEMIC HEALTH PAIN IN THE EMERGENCY Upstate University Hospital INTESTINAL TRANSPLANT Kortney Morrell, PharmD Lenox Hill Hospital SYSTEM DEPARTMENT RECIPIENTS St. Peter’s Hospital Cyrille Cornelio, PharmD Ines Tebas-Pueyo, PharmD Daryl Nnani, PharmD Montefiore Medical Center Southside Hospital Mount Sinai Hospital 10:00am – SUSTAINED VIRAL EFFECT OF VOCERA® ON SEDATION REQUIREMENTS IMPACT OF A IMPACT OF A HIGH RISK ENGRAFTMENT WITH 10:20am RESPONSE RATES DECREASING STAT IN VENOVENOUS AND MULTIDISCIPLINARY CARE MEDICATON FILGRASTIM-SNDZ VERSUS FOLLOWING POLICY MEDICATION VENOARTERIAL EXTRA BUNDLE FOR PATIENTS DEPRESCRIBING FILGRASTIM IN ADULT CRITERIA CHANGE FOR THE ADMINISTRATION TIME CORPOREAL MEMBRANE PRESENTING TO THE PROCEDURE IN GERIATRIC AUTOLOGOUS STEM CELL TREATMENT OF CHRONIC Tiffany Wong, PharmD OXYGENATION (ECMO) EMERGENCY DEPARTMENT PATIENTS IN A HOSPITAL TRANSPLANT PATIENTS HEPATITIS C Lenox Hill Hospital Mitulkumar Patel, PharmD WITH ASTHMA OR BASED TRANSITIONAL Ruby Lee, PharmD Julieta Garcia, PharmD NYU Langone Health CHRONIC OBSTRUCTIVE CARE UNIT North Shore University Capital District Physicians PULMONARY DISEASE Elizabeth Feldman, PharmD Hospital Health Plan Julia Cullen, PharmD Upstate University Hospital Mount Sinai Beth Israel Community Campus
Session 4: Saturday 10:30 – 11:50am Time of Room: Broadway 1 Room: Broadway 2 Room: Broadway 3 Room: Broadway 4 Room: Phila Room: Travers Presentations Infectious Disease Practice Management/ Critical Care Emergency Medicine Anticoagulation Medicine Moderator Dr. Bryan Mogle Ms. Jill Pogodzinski Dr. Joseph Palumbo Dr. Tamara Wanchisen Dr. Chung-Shien Lee Evaluators Dr. Carley Luker Dr. Luke Probst Dr. Michael Biglow Dr. Joel Costanzo Dr. Emma Gorman Dr. Alecia Wyckoff Dr. Leslie Riddle Dr. Maria Sorbera Dr. Daniella Rodrigues Ferri Ms. Karen Whalen 10:30am – EVALUATION OF A EVALUATING THE ACCURACY TIME TO SEPTIC SHOCK EFFECT OF EARLY EVALUATING THE IMPACT 10:50am PHARMACIST-DRIVEN OF HOME MEDICATION RESOLUTION IN PATIENTS ELECTRONIC NOTIFICATION OF A HEPARIN MONITORING PNEUMOCOCCAL HISTORY COLLECTION AND ON OUTPATIENT OF AN EMERGENCY SYSTEM ON NURSE-DRIVEN, VACCINATION PROTOCOL RECONCILIATION AT A ANTIHYPERTENSIVE DEPARTMENT PHARMACIST AUTOMATED HEPARIN Corey Wells, PharmD TERTIARY HOSPITAL MEDICATIONS ON SEPSIS BUNDLE NOMOGRAM USE Buffalo General Medical Stephanie Tchen, PharmD Myroslava Sharabun, PharmD COMPLIANCE Michelle Min, PharmD Center St. Peter’s Hospital The Mount Sinai Hospital Jaclyn Healy, PharmD North Shore University Mercy Hospital of Buffalo Hospital 10:50am – IMPLEMENTATION OF A IMPACT OF A PHARMACY- VITAMIN C, THIAMINE, AND EVALUATION OF A REDUCING THE 11:10am PHARMACY RESIDENT DRIVEN TRANSITION-OF- HYDROCORTISONE BUNDLE PHARMACIST-MANAGED INAPPROPRIATE USE OF REFERRAL SYSTEM TO CARE PROGRAM IN AN FOR THE TREATMENT OF CULTURE REVIEW PROCESS INTRAVENOUS HEPARIN IMPROVE PNEUMOCOCCAL INPATIENT BEHAVIORAL SEPTIC SHOCK IN THE EMERGENCY WITH PHARMACIST VACCINATION RATES IN A HEALTH UNIT Annh Vo, PharmD DEPARTMENT INTERVENTION COMMUNITY HOSPITAL Courtney Cardinal, PharmD Kingsbrook Jewish Medical Magdalena Wrzesinski, Arfa Rehman, PharmD Aleksandr Sorokin, PharmD Niagara Falls Memorial Center PharmD Huntington Hospital Mount Sinai Brooklyn Medical Center Buffalo General Medical Center 11:10am – EVALUATING PHARMACIST- ASSESSING THE EFFECT OF OUTCOMES OF WEIGHT- ASSESSING THE EFFECTS OF TWICE VERSES THRICE DAILY 11:30am LED INTERVENTIONS IN THE PHARMACIST-DRIVEN BASED DOSING OF A PHARMACIST-LED UNFRACTIONATED HEPARIN MANAGEMENT OF URINARY MEDICATION NOREPINEPHRINE IN OBESE EMERGENCY DEPARTMENT FOR VENOUS TRACT INFECTIONS RECONCILATION SERVICES PATIENTS WITH SHOCK CULTURE REVIEW AND THROMBOEMBOLISM Paris Cook, PharmD ON MEDICATION ERRORS AT Courtney Jarka, PharmD FOLLOW-UP SERVICE PROPHYLAXIS IN CRITICALLY Northwell Health - HOSPITAL DISCHARGE Mercy Hospital of Buffalo Joe Aladeen, PharmD ILL PATIENTS Huntington Hospital Lawrence Chang, PharmD Niagara Falls Memorial Nicole Davis, PharmD Upstate University Hospital, Medical Center Mount Sinai Hospital 11:30am – IMPACT OF INFECTIOUS EVALUATION OF A SUCCESSFUL 11:50am DISEASES CONSULTATIONS MEDICATION EDUCATION IMPLEMENTATION OF AND OUTPATIENT FOLLOW- TOOL IMPLEMENTED VASOPRESSIN STEWARDSHIP UP ON CLINICAL OUTCOMES ACROSS GENERAL MEDICINE, AT MONTEFIORE MEDICAL OF PATIENTS WITH SURGERY, AND CARDIOLOGY CENTER VASCULAR LOWER FLOORS Tamara Yunusova, PharmD EXTREMITY INFECTIONS Neha Kumar, PharmD Montefiore Medical Center Kathryn Bui, PharmD New York-Presbyterian/Weill Mount Sinai St. Luke’s Cornell Medical Center Hospital
CONTINUING EDUCATION CREDITS: The NYSCHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. This program 0134-0000-18-081-L04-P, (Friday AM session) is approved for 0.15 CEU's (1.5 contact hours); and 0134-0000-18-082-L04-P (Friday PM Session) is approved for .1 CEU’s (1 contact hour). This program 0134-0000-18-083-L04-P, (Saturday AM session) is approved for 0.15 CEU's (1.5 contact hours); and 0134-0000-18-084-L04-P (Saturday PM Session) is approved for .15 CEU’s (1.5 contact hours). Statements of Continuing Pharmacy Education Credit are available at CPE Monitor at nabp.pharmacy.com to participants upon the conclusion of the program. Participant must verify attendance at the meeting by entering the program CE code.
Attendees have 45 days from the date of the program to retrieve their credits. Payments to NYSCHP are not deductible as charitable contributions for federal income tax purposes. However, they may be deductible under other provisions of the Internal Revenue Code (i.e., ordinary, necessary business expenses; miscellaneous itemized deduction).